首站-论文投稿智能助手
典型文献
Surgical management and molecular diagnosis of persistent Müllerian duct syndrome in Chinese patients
文献摘要:
Persistent Mullerian duct syndrome(PMDS)is a rare clinically and genetically overlapping disorder caused by mutations in the anti-Müillerian hormone(AMH)gene or the anti-Mullerian hormone receptor type 2(AMHR2)gene.Affected individuals present uterus and tubes in normally virilized males and are discovered unexpectedly during other surgeries.Since it is rare and complex,a definitive clinical diagnosis can be missed,and there are no guidelines regarding how to deal with the uterus.In the present study,exome sequencing and Sanger verification were performed for causal variants in 12 PMDS patients.Preoperative diagnoses were made by positive exome sequencing in 8 patients.Of them,7 patients evoked on the basis of ultrasound indicating bilateral testes on the same side of the body.Twelve different AMH variants(2 frameshift/nonsense,1 deletion,8 missense,and 1 in-frame)in 9 patients and 6 different AMHR2 variants(5 missense and 1 splicing)in 3 patients were identified.Seven variants were classified as"pathogenic"or"likely pathogenic",and 4 of them were novel.All but two patients with AMH defects showed low serum AMH concentrations,but all patients with AMHR2 defects showed elevated AMH levels.During surgery,an abnormal vas deferens was observed in half of the patients.Eight patients underwent orchidopexy with uterine preservation.Of them,2 patients presented complications including irreducible cryptorchidism,and 3 patients developed Mullerian remnant cysts.Three patients underwent subtotal hysterectomy.Of them,one patient had complication of injury to the vas deferens,and one had hemorrhage after operation.This is the first report of PMDS involving a large Chinese population.The present study not only expands the variation spectrum but also provides clinical experience about the management of the uterus.
文献关键词:
作者姓名:
Hong-Juan Tian;De-Hua Wu;Wei Ru;Ding-Wen Wu;Chang Tao;Guang-Jie Chen;Jin-Na Yuan;Jun-Fen Fu;Da-Xing Tang
作者机构:
Department of Urology,Children's Hospital,Zhejiang University School of Medicine,National Clinical Research Center for Child Health,Hangzhou 310052,China;Department of Genetics and Metabolism,Children's Hospital,Zhejiang University School of Medicine,National Clinical Research Center for Child Health,Hangzhou 310052,China;Department of Endocrinology,Children's Hospital,Zhejiang University School of Medicine,National Clinical Research Center for Child Health,Hangzhou 310052,China
引用格式:
[1]Hong-Juan Tian;De-Hua Wu;Wei Ru;Ding-Wen Wu;Chang Tao;Guang-Jie Chen;Jin-Na Yuan;Jun-Fen Fu;Da-Xing Tang-.Surgical management and molecular diagnosis of persistent Müllerian duct syndrome in Chinese patients)[J].亚洲男性学杂志(英文版),2022(01):78-84
A类:
illerian,virilized,orchidopexy,cryptorchidism
B类:
Surgical,management,molecular,diagnosis,persistent,duct,syndrome,Chinese,patients,Persistent,Mullerian,PMDS,rare,clinically,genetically,overlapping,disorder,caused,by,mutations,anti,hormone,receptor,type,AMHR2,Affected,individuals,uterus,tubes,normally,males,discovered,unexpectedly,during,other,surgeries,Since,complex,definitive,can,missed,there,guidelines,regarding,deal,In,study,exome,sequencing,Sanger,verification,were,performed,causal,variants,Preoperative,diagnoses,made,positive,Of,them,evoked,basis,ultrasound,indicating,bilateral,testes,same,side,body,Twelve,different,frameshift,nonsense,deletion,missense,splicing,identified,Seven,classified,pathogenic,likely,novel,All,but,two,defects,showed,low,serum,concentrations,elevated,levels,During,surgery,abnormal,vas,deferens,was,observed,half,Eight,underwent,uterine,preservation,presented,complications,including,irreducible,developed,remnant,cysts,Three,subtotal,hysterectomy,had,injury,hemorrhage,after,operation,This,first,report,involving,large,population,not,only,expands,variation,spectrum,also,provides,experience,about
AB值:
0.547635
相似文献
Urinary bladder cancer as a late sequela of traumatic spinal cord injury
Ralf Böthig;Christian Tiburtius;Wolfgang Schöps;Michael Zellner;Oliver Balzer;Birgitt Kowald;Sven Hirschfeld;Roland Thietje;Aki Pietsch;Ines Kurze;Martin Forchert;Thura Kadhum;Klaus Golka-Department of Neuro-Urology,Centre for Spinal Cord Injuries,BG Klinikum Hamburg,21033 Hamburg,Germany;Urological Practice,53757 Sankt Augustin,Germany;Department of Urology and Neuro-Urology,Johannesbad Fachklinik,94072 Bad Füssing,Germany;Biomechanical Laboratory,Centre for Spinal Cord Injuries,BG Klinikum Hamburg,21033 Hamburg,Germany;Centre for Spinal Cord Injuries,BG Klinikum Hamburg,21033 Hamburg,Germany;Department of Sports and Rehabilitation Medicine,BG Klinikum Hamburg,21033 Hamburg,Germany;Department of Paraplegiology and Neuro-Urology,Centre for Spinal Cord Injuries,Zentralklinik Bad Berka,99437 Bad Berka,Germany;Staff Position Accident Insurance Law,Statutory Accident Insurance for Wood and Metal(BGHM),33602 Bielefeld,Germany;Department of Psychosomatic Rehabilitation,Mittelrheinklinik Fachklinik,56154 Boppard-Bad Salzig,Germany;Clinical Occupational Medicine,Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund(IfADo),44139 Dortmund,Germany
Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID?19 in a Han Chinese population from Central China
Yi Wu;Xian‑Hui Wang;Xi‑Hua Li;Li‑Yuan Song;Shi‑Long Yu;Zhi‑Cheng Fang;Yu‑Quan Liu;Le‑Yong Yuan;Chun‑Yan Peng;Shen‑Yi Zhang;Wang Cheng;Hong‑Chao Ma;Li‑Feng Wang;Jun‑Ming Tang;Yun‑Fu Wang;Fu‑Yun Ji-Department of Medical Biology,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Biomedical Research,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Human Respiratory Disease,Xinqiao Hospital,The Army Medical University(Third Military Medical University),400037 Chongqing,China;Department of Emergency Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Geriatric Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Immunology,School of Basic Medical Sciences,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Laboratory Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Hubei Key Laboratory of Embryonic Stem Cell Research,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Neurology,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu;Ting Li;Zhichao Liao;Hui Yu;Yongtian Zhao;Haixiao Wu;Zhiwu Ren;Jun Zhao;Ruwei Xing;Sheng Teng;Yun Yang;Xiangchun Li;Kexin Chen;Jonathan Trent;Jilong Yang-Department of Bone and Soft Tissue Tumor,2Department of Infection Management,3Key Laboratory of Molecular Cancer Epidemiology,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;YuceBio Technology Co.,Ltd.,Shenzhen 518172,China;Department of Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;Sarcoma Multidisciplinary Program,Sylvester Comprehensive Cancer Center,The University of Miami,Miami,FL 33136,USA
Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
Yan Li;Lihong Fan;Jianming Zheng;Xiu Nie;Yu Sun;Qin Feng;Shenyi Lian;Wenqi Bai;Weijing Cai;Yanan Yang;Bo Su;Yanfeng Xi;Dongmei Lin-Department of Pathology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Respiration Medicine,Shanghai Tenth People's Hospital,School of Medicine,Tongji University,Shanghai 200072,China;Department of Pathology,Changhai Hospital of Shanghai,Shanghai 200433,China;Department of Pathology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Colorectal Surgery,Shanxi Cancer Hospital,Taiyuan 030013,China;Shanghai Tongshu Biotechnology Co.,Ltd,Shanghai 200120,China;Department of Biochemistry and Molecular Biology,Mayo Clinic,Rochester,MN 55905,USA;Central Laboratory,Shanghai Pulmonary Hospital,School of Medicine,Tongji University,Shanghai 200433,China;Department of Pathology,Shanxi Cancer Hospital,Taiyuan 030013,China
Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program
Wu Zheng;Tan Fengwei;Yang Zhuoyu;Wang Fei;Cao Wei;Qin Chao;Dong Xuesi;Zheng Yadi;Luo Zilin;Zhao Liang;Yu Yiwen;Xu Yongjie;Ren Jiansong;Shi Jufang;Chen Hongda;Li Jiang;Tang Wei;Shen Sipeng;Wu Ning;Chen Wanqing;Li Ni;He Jie-Office of Cancer Screening, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Key Laboratory of Cancer Data Science, Chinese Academy of Medical Sciences, Beijing 100021, China;Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;PET-CT Center, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Department of Diagnostic Radiology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity
Liu Zuojing;Zhu Shiwei;He Meibo;Li Mo;Wei Hui;Zhang Lu;Sun Qinghua;Jia Qiong;Hu Nan;Fang Yuan;Song Lijin;Zhou Chen;Tao Heqing;Y Kao John;Zhu Huaiqiu;Owyang Chung;Duan Liping-Department of Gastroenterology, Peking University Third Hospital, Haidian District, Beijing 100191, China;Department of Ultrasound, Peking University Third Hospital, Haidian District, Beijing 100191, China;Institute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China;Department of Biomedical Engineering, College of Engineering, Peking University, Beijing 100187, China;Division of Gastroenterology, Department of Internal Medicine, University of Michigan Health System, 6520 MSRB I, SPC 5682, 1150 West Medical Center Drive, Ann Arbor, MI 48109, USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。